Page last updated: 2024-10-24

glutamate catabolic process to 2-oxoglutarate

Definition

Target type: biologicalprocess

The chemical reactions and pathways resulting in the breakdown of glutamate into other compounds, including 2-oxoglutarate. [GOC:go_curators]

Glutamate catabolism to 2-oxoglutarate is a central metabolic process that occurs in both the brain and other tissues. It plays a vital role in the regulation of neurotransmitter levels, energy production, and amino acid biosynthesis.

The process begins with the conversion of glutamate, a neurotransmitter, to alpha-ketoglutarate, an intermediate in the citric acid cycle. This reaction is catalyzed by the enzyme glutamate dehydrogenase (GDH). GDH is a mitochondrial enzyme that uses NAD+ as a cofactor.

**Step 1: Transamination**
Glutamate can be converted to alpha-ketoglutarate through transamination reactions. In these reactions, the amino group of glutamate is transferred to another molecule, such as pyruvate, to form alanine. This reaction is catalyzed by aminotransferases.

**Step 2: Oxidative Deamination**
Glutamate can also be converted to alpha-ketoglutarate through oxidative deamination. In this reaction, the amino group of glutamate is removed as ammonia. This reaction is catalyzed by glutamate dehydrogenase (GDH).

**Glutamate Dehydrogenase (GDH)**
GDH is a mitochondrial enzyme that catalyzes the reversible conversion of glutamate to α-ketoglutarate. It uses NAD+ as a cofactor and can utilize ammonia or other amines as the amino group acceptor. The reaction is highly regulated and is influenced by various factors, including:

* **Energy Levels:** GDH activity is stimulated by high levels of ADP and inhibited by high levels of ATP. This ensures that glutamate catabolism occurs when energy demands are high.
* **Amino Acid Levels:** GDH activity is inhibited by high levels of glutamate and other amino acids. This helps to maintain a balance of amino acids in the body.
* **Hormonal Regulation:** GDH activity is regulated by various hormones, including insulin and glucagon.

**Regulation of Glutamate Catabolism:**
The catabolism of glutamate is tightly regulated to maintain the balance of neurotransmitters and energy production. Factors that influence glutamate catabolism include:

* **Neurotransmitter Demand:** When neuronal activity is high, the demand for glutamate increases. This leads to increased glutamate catabolism to replenish the neurotransmitter pool.
* **Energy Requirements:** During periods of high energy demand, glutamate catabolism is stimulated to provide α-ketoglutarate for the citric acid cycle.
* **Amino Acid Availability:** The availability of other amino acids, such as alanine and aspartate, can influence glutamate catabolism.

**Importance of Glutamate Catabolism:**
Glutamate catabolism plays a crucial role in several important biological processes:

* **Neurotransmitter Regulation:** The conversion of glutamate to α-ketoglutarate helps to maintain the balance of neurotransmitters in the brain.
* **Energy Production:** α-ketoglutarate is an intermediate in the citric acid cycle, which is the main pathway for energy production in the body.
* **Amino Acid Biosynthesis:** α-ketoglutarate can be used as a precursor for the synthesis of other amino acids, such as glutamine and proline.

**Disorders Related to Glutamate Catabolism:**
Dysregulation of glutamate catabolism can lead to several neurological and metabolic disorders, including:

* **Neurodegenerative Diseases:** Glutamate excitotoxicity has been implicated in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
* **Hyperammonemia:** Excessive ammonia production due to impaired glutamate catabolism can lead to hyperammonemia, a potentially life-threatening condition.

**Conclusion:**
Glutamate catabolism to 2-oxoglutarate is an essential metabolic pathway that plays a critical role in neurotransmitter regulation, energy production, and amino acid biosynthesis. The process is tightly regulated to maintain the balance of these vital functions. Dysregulation of glutamate catabolism can contribute to various neurological and metabolic disorders.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Aspartate aminotransferase, cytoplasmicAn aspartate aminotransferase, cytoplasmic that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17174]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
hydralazinehydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
azaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines
antihypertensive agent;
vasodilator agent
hydralazine hydrochloridehydralazine hydrochloride : The hydrochloride salt of hydralazine; a direct-acting vasodilator that is used as an antihypertensive agent.hydrochlorideantihypertensive agent;
vasodilator agent
dihydralazineDihydralazine: 1,4-Dihydrazinophthalazine. An antihypertensive agent with actions and uses similar to those of HYDRALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p354)phthalazines
adapaleneadapalene : A naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether.

Adapalene: A naphthalene derivative that has specificity for RETINOIC ACID RECEPTORS. It is used as a DERMATOLOGIC AGENT for the treatment of ACNE.
adamantanes;
monocarboxylic acid;
naphthoic acid
dermatologic drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
non-steroidal anti-inflammatory drug
ziprasidoneziprasidone : A piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.

ziprasidone: a benzisothiazoylpiperazine derivative; has combined dopamine and serotonin receptor antagonist activity; structurally related to tiospirone
1,2-benzisothiazole;
indolones;
organochlorine compound;
piperazines
antipsychotic agent;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
psychotropic drug;
serotonergic antagonist
aminopyridazineaminopyridazine: structure in first source